The Role of Endocrine-Disrupting Chemicals in the Development of Cardiovascular Diseases

A special issue of Journal of Xenobiotics (ISSN 2039-4713). This special issue belongs to the section "Drug Therapeutics".

Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 627

Special Issue Editor


E-Mail Website
Guest Editor
1. CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal
2 FCS—UBI, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal
Interests: endocrine disruptors; human exposome; pregnancy exposome; phthalates; flame retardants; UVB-filters; bisphenols; cardiovascular endocrinology; fetoplacental vasculature; vascular smooth muscle cells; neurovascular unit; hypertensive disorders in pregnancy; hypothyroidism; calcium and potassium channels; sex hormones; patch clamp
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is with great pleasure that I announce this Special Issue on “The Role of Endocrine-Disrupting Chemicals in the Development of Cardiovascular Diseases”.

Cardiovascular diseases (CVD) are a major cause of mortality and mobility worldwide. Throughout life, humans are exposed to a wide range of emerging contaminants (EDC). Exposure to these EDC is a global concern due to their adverse effects on the human endocrine system, including the CV system. Moreover, the cellular and molecular mechanisms by which EDC interact with hormonal action are complex and difficult to understand. For this reason, knowledge of these mechanisms is one of the current challenges of CV research.

This Special Issue will focus on the advances of emerging contaminants’ role on the human cardiovascular system. The aim is to provide an integrative, novel, and transdisciplinary approach to evaluate actual human exposure to EDC and contribute to the prevention and treatment of CVD. The theme is multidisciplinary, so I invite you to submit original research and review articles on the following non-exhaustive list of topics:

  • Environmental health;
  • Risk assessment;
  • Health impact assessment;
  • Endocrine-disrupting chemicals;
  • Cellular and molecular mechanistic;
  • Electrophysiology studies;
  • Molecular docking.

Prof. Elisa Cairrao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Xenobiotics is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vascular diseases
  • endocrine disruption
  • environmental compounds
  • cardiovascular risk
  • humans

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop